G6PD and G6PD deficiency: However, a quantitative point-of-care test to measure G6PD activity (STANDARD G6PD test),43 which was developed by SD Biosensor (Suwon, South Korea) in 2018, has received interim approval from the Expert Review Panel for Diagnostics,44 allowing for increased use to identify patients with different degrees of G6PD deficiency, so that radical cure regimens can be adjusted accordingly.